Julie Huynh, Yara-Natalie Abo, Rina Triasih, Varinder Singh, Gordon Pukai, Pauline Masta, Bazarragchaa Tsogt, Boi Khanh Luu, Felisia Felisia, Naomi Pank, Aung Aung, Alison Morton, Pete Azzopardi, Raspati C Koesoemadinata, Bachti Alisjahbana, Philip C Hill, Ben J Marais, Silvia S Chiang, Stephen M Graham
{"title":"Emerging evidence to reduce the burden of tuberculosis in children and young people.","authors":"Julie Huynh, Yara-Natalie Abo, Rina Triasih, Varinder Singh, Gordon Pukai, Pauline Masta, Bazarragchaa Tsogt, Boi Khanh Luu, Felisia Felisia, Naomi Pank, Aung Aung, Alison Morton, Pete Azzopardi, Raspati C Koesoemadinata, Bachti Alisjahbana, Philip C Hill, Ben J Marais, Silvia S Chiang, Stephen M Graham","doi":"10.1016/j.ijid.2025.107869","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis (TB) remains a major global health challenge. Children, adolescents and young mothers are high-risk populations for TB with unique challenges and needs. Children are often misdiagnosed or diagnosed too late, resulting in long-term sequelae or mortality, whilst adolescents, despite having more recognisable adult-type TB and being an important source of community transmission, can be difficult to engage in care as they often fall between paediatric and adult models of care. TB during pregnancy poses significant risks to the mother-infant pair, yet antenatal screening to ensure timely treatment initiation is often inadequate. Recent research advancements to address these challenges include more accessible TB management aids, shorter effective drug regimens, child-friendly drug formulations, strategies for active case finding to expand treatment coverage including of asymptomatic disease and more options for preventive therapy. These advances have informed global policy and guidelines; however, major gaps in translation from policy to practice remain. This narrative review discusses the progress and identifies potential solutions with insights from the Asia-Pacific region to ongoing challenges in TB detection, treatment, and prevention in children and young people, with a view to TB elimination.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107869"},"PeriodicalIF":4.8000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.107869","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Tuberculosis (TB) remains a major global health challenge. Children, adolescents and young mothers are high-risk populations for TB with unique challenges and needs. Children are often misdiagnosed or diagnosed too late, resulting in long-term sequelae or mortality, whilst adolescents, despite having more recognisable adult-type TB and being an important source of community transmission, can be difficult to engage in care as they often fall between paediatric and adult models of care. TB during pregnancy poses significant risks to the mother-infant pair, yet antenatal screening to ensure timely treatment initiation is often inadequate. Recent research advancements to address these challenges include more accessible TB management aids, shorter effective drug regimens, child-friendly drug formulations, strategies for active case finding to expand treatment coverage including of asymptomatic disease and more options for preventive therapy. These advances have informed global policy and guidelines; however, major gaps in translation from policy to practice remain. This narrative review discusses the progress and identifies potential solutions with insights from the Asia-Pacific region to ongoing challenges in TB detection, treatment, and prevention in children and young people, with a view to TB elimination.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.